Plasma Copeptin, A Unifying Factor behind the Metabolic Syndrome
Abstract
CONTEXT: Arginine vasopressin (AVP) is known to affect liver glycogenolysis, insulin, and glucagon secretion and pituitary ACTH release. We previously showed that high copeptin, the stable C-terminal fragment of AVP prohormone, is independently associated with hyperinsulinemia and future development of diabetes mellitus. OBJECTIVE: The objective of the study was to examine whether plasma copeptin is associated with components of the metabolic syndrome (MetS) independently of insulin, diabetes mellitus, and environmental factors. DESIGN, SETTING, AND PARTICIPANTS: This was a cross-sectional, population-based sample of 4742 subjects, aged 46-68 yr, 60% women, in Malmö, Sweden. MAIN OUTCOME MEASURE: Using multivariable logistic and linear regression, plasma copeptin was associated with components of the MetS. RESULTS: Copeptin quartile (lowest quartile as reference) was, after adjustment for age, sex, insulin, and diabetes mellitus, associated with hypertension (odds ratios 1.04, 1.07, 1.31; P = 0.004), abdominal obesity (odds ratios 1.21, 1.16, 1.57; P = 0.002), obesity (odds ratios 1.25, 1.15, 1.49; P = 0.01), top quartile of c-reactive protein (odds ratios 1.11, 1.13, 1.32; P = 0.007), and MetS (adjusted for age and sex only) (odds ratios 1.53, 1.77, 1.86; P < 0.001). High copeptin levels were significantly associated with high fat intake, low physical activity, and borderline significantly associated with low socioeconomic status. The association between copeptin and components of the MetS was not affected after adjustment for these environmental factors. CONCLUSIONS: Our data suggest that increased activity of the AVP system is a unifying factor in the MetS and point to a new pharmacologically modifiable system of potential importance in the treatment of MetS and prevention of cardiovascular disease.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Levels of copeptin are increased in individuals with obesity and insulin resistance.
“As levels of copeptin are increased in individuals with obesity and IR (12, 43)”
From Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS (2018) · cites this paper as [43]
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198 · see citing works
A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure
Appel, L. J., Moore, T. J., Obarzanek, E., Vollmer, W. M., Svetkey, L. P., Sacks, F. M., Bray, G. A., Vogt, T. M., Cutler, J. A., Windhauser, M. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361601 · Cited by 5,981 · see citing works
A questionnaire for the assessment of leisure time physical activities
Taylor, H. L., Jacobs, D. R., Schucker, B., Knudsen, J., Leon, A. S., & Debacker, G. (1978) · Journal of Chronic Diseases · doi:10.1016/0021-9681(78)90058-9 · Cited by 1,848 · see citing works
Grundy, S. M. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.151092 · Cited by 1,571 · see citing works
Tolvaptan, a Selective Oral Vasopressin V <sub>2</sub> -Receptor Antagonist, for Hyponatremia
Schrier, R. W., Gross, P., Gheorghiade, M., Berl, T., Verbalis, J. G., Czerwiec, F. S., & Orlandi, C. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa065181 · Cited by 1,215 · see citing works
Berglund, G., Elmståhl, S., Janzon, L., & LARSSON, S. A. (1993) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1993.tb00647.x · Cited by 640 · see citing works
Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age
Antoni, F. A. (1993) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1993.1004 · Cited by 636 · see citing works
Lolait, S. J., O'Carroll, A.-M., McBride, O. W., Konig, M., Morel, A., & Brownstein, M. J. (1992) · Nature · doi:10.1038/357336a0 · Cited by 524 · see citing works
Gender Differences in Social Desirability and Social Approval Bias in Dietary Self-report
Hébert, J. R., Ma, Y., Clemow, L., Ockene, I. S., Saperia, G. M., Stanek, E. J., Merriam, P. A., & Ockene, J. K. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009233 · Cited by 522 · see citing works
Molecular cloning and expression of a rat Via arginine vasopressin receptor
Morel, A., O'Carroll, A.-M., Brownstein, M. J., & Lolaft, S. J. (1992) · Nature · doi:10.1038/356523a0 · Cited by 477 · see citing works
Plasma Copeptin and the Risk of Diabetes Mellitus
Enhörning, S., Wang, T. J., Nilsson, P. M., Almgren, P., Hedblad, B., Berglund, G., Struck, J., Morgenthaler, N. G., Bergmann, A., Lindholm, E., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.909663 · Cited by 299 · see citing works
Self-citationStruck, J., Morgenthaler, N. G., & Bergmann, A. (2005) · Peptides · doi:10.1016/j.peptides.2005.04.019 · Cited by 240 · see citing works
Self-citationThe Malmo Food Study: validity of two dietary assessment methods for measuring nutrient intake
Ríboli, E. (1997) · International Journal of Epidemiology · doi:10.1093/ije/26.suppl_1.s161 · Cited by 238 · see citing works
Prospective study of alcohol consumption and metabolic syndrome
Baik, I., & Shin, C. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1455 · Cited by 236 · see citing works
Jensen, K. O., & Holm, L. (1999) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600767 · Cited by 231 · see citing works
Voors, A. A., von Haehling, S., Anker, S. D., Hillege, H. L., Struck, J., Hartmann, O., Bergmann, A., Squire, I., van Veldhuisen, D. J., Dickstein, K., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp098 · Cited by 222 · see citing works
Self-citationCopeptin in the Differential Diagnosis of Hyponatremia
Fenske, W., Störk, S., Blechschmidt, A., Maier, S. G. K., Morgenthaler, N. G., & Allolio, B. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1426 · Cited by 212 · see citing works
Self-citationCloning and characterization of the human V3 pituitary vasopressin receptor
de Keyzer, Y., Auzan, C., Lenne, F., Beldjord, C., Thibonnier, M., Bertagna, X., & Clauser, E. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01268-7 · Cited by 209 · see citing works
Saleem, U., Khaleghi, M., Morgenthaler, N. G., Bergmann, A., Struck, J., Mosley, T. H., & Kullo, I. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2278 · Cited by 161 · see citing works
Self-citationPersson, M., Hedblad, B., Nelson, J. J., & Berglund, G. L. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.142679 · Cited by 151 · see citing works
Self-citationWirfält, E., Mattisson, I., Johansson, U., Gullberg, B., Wallström, P., & Berglund, G. L. (2002) · Nutrition Journal · doi:10.1186/1475-2891-1-3 · Cited by 140 · see citing works
Self-citationRosvall, M. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.4.334 · Cited by 127 · see citing works
Alteration of Glucose Homeostasis in V1a Vasopressin Receptor-Deficient Mice
Aoyagi, T., Birumachi, J.-I., Hiroyama, M., Fujiwara, Y., Sanbe, A., Yamauchi, J., & Tanoue, A. (2007) · Endocrinology · doi:10.1210/en.2006-1315 · Cited by 113 · see citing works
Hypermetabolism of Fat in V1a Vasopressin Receptor Knockout Mice
Hiroyama, M., Aoyagi, T., Fujiwara, Y., Birumachi, J., Shigematsu, Y., Kiwaki, K., Tasaki, R., Endo, F., & Tanoue, A. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0069 · Cited by 95 · see citing works
Glucocorticoids Increase Vasopressin V1b Receptor Coupling to Phospholipase C
Rabadan-Diehl, C., & Aguilera, G. (1998) · Endocrinology · doi:10.1210/endo.139.7.6121 · Cited by 78 · see citing works
Mechanism of vasopressin-induced platelet aggregation
Filep, J. G., & Rosenkranz, B. (1987) · Thrombosis Research · doi:10.1016/0049-3848(87)90252-0 · Cited by 76 · see citing works
Folny, V., Raufaste, D., Lukovic, L., Pouzet, B., Rochard, P., Pascal, M., & Serradeil-Le Gal, C. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00148.2003 · Cited by 61 · see citing works
Elasmi, M., Taieb, S. H., Hsairi, M., et al. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.11.009 · Cited by 56 · see citing works
Misra, K. B., Endemann, S. W., & Ayer, M. (2005) · PubMed · Cited by 55 · see citing works
Pollard, A. D., & Brindley, D. N. (1984) · Biochemical Journal · doi:10.1042/bj2170461 · Cited by 51 · see citing works
Abraham, N. G., Brunner, E. J., Eriksson, J. W., & Robertson, R. P. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1391.015 · Cited by 51 · see citing works
Zenteno‐Savín, T., Sada‐Ovalle, I., Ceballos, G. M., et al. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00853-0 · Cited by 47 · see citing works
Masulli, M., Riccardi, G., Galasso, R., et al. (2005) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.06.005 · Cited by 46 · see citing works
Mellbin, L., Rydén, L., Brismar, K., Morgenthaler, N. G., Öhrvik, J., & Catrina, S. (2010) · Diabetes Care · doi:10.2337/dc10-0088 · Cited by 39 · see citing works
Self-citationHuman vascular vasopressin receptors: analysis with selective vasopressin receptor antagonists.
Ohlstein, E. H., & Berkowitz, B. A. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23348-1 · Cited by 38 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Vasopressin: a novel target for the prevention and retardation of kidney disease?
Bankir, L., Bouby, N., & Ritz, E. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.22 · Cited by 214 · see citing works
Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS
Frøssing, S., Nylander, M., Kistorp, C., Skouby, S. O., & Faber, J. (2018) · Endocrine Connections · doi:10.1530/ec-17-0327 · Cited by 38 · see citing works
Karbek, B., Ozbek, M., Karakose, M., Topaloglu, O., Bozkurt, N., Cakır, E., Aslan, M., & Delibasi, T. (2014) · Journal of Ovarian Research · doi:10.1186/1757-2215-7-31 · Cited by 35 · see citing works
Asferg, C. L., Andersen, U. B., Linneberg, A., Goetze, J. P., & Jeppesen, J. L. (2014) · Diabetic Medicine · doi:10.1111/dme.12411 · Cited by 26 · see citing works
- Authors
- Enhörning, S., Struck, J., Wirfält, E., Hedblad, B., Morgenthaler, N. G., & Melander, O.
- Affiliations
- Lund University (SE)
- Thermo Fisher Scientific (Germany) (DE)
- Corresponding author
- Enhörning, Sofia
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-07
- Volume
- 96
- Issue
- 7
- Pages
- E1065-E1072
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2131511074
- Semantic Scholar
- a2146ab823664c64adb083f20a8489e163bb66b4
- Cited by
- 177
- References
- 36
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 12 · 2023: 8 · 2022: 8 · 2021: 17 · 2020: 16 · 2019: 15 · 2018: 16 · 2017: 15 · 2016: 15 · 2015: 13 · 2014: 10 · 2013: 11 · 2012: 5
- FWCI
- 6.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Electrolyte and hormonal disorders
- Keywords
- copeptin, vasopressin, metabolic syndrome, hypertension, abdominal obesity, obesity, C-reactive protein, hyperinsulinemia, diabetes mellitus, dietary fat intake, physical activity, socioeconomic status, cardiovascular disease prevention
- MeSH terms
- Aged, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Dietary Fats, Female, Glycopeptides, Humans, Insulin, Insulin Resistance, Life Style, Male, Middle Aged, Motor Activity, Obesity, Prospective Studies, Social Class, Sweden, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
